Creative Medical Technology Holdings, Inc.
CELZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 22.2% | -89.8% | 1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60% | 60% | 67.8% | 45.4% |
| R&D Expenses | $2 | $2 | $6 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $4 | $4 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $6 | $10 | $3 |
| Operating Income | -$6 | -$6 | -$10 | -$3 |
| % Margin | -52,216.9% | -62,445.9% | -11,562.5% | -3,562.2% |
| Other Income/Exp. Net | $0 | $0 | $0 | $22 |
| Pre-Tax Income | -$5 | -$5 | -$10 | $19 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$5 | -$10 | $19 |
| % Margin | -49,940.7% | -58,739.7% | -11,449.3% | 21,892.8% |
| EPS | -3.71 | -3.76 | -9.28 | 73.75 |
| % Growth | 1.3% | 59.5% | -112.6% | – |
| EPS Diluted | -3.71 | -3.76 | -9.28 | 56.1 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $4 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$6 | -$10 | $24 |
| % Margin | -51,212.8% | -61,395% | -11,458.6% | 26,873.2% |